Boothbay Fund Management, LLC Celldex Therapeutics, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.27 Billion
- Q4 2024
A detailed history of Boothbay Fund Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 60,900 shares of CLDX stock, worth $1.23 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
60,900
Previous 90,200
32.48%
Holding current value
$1.23 Million
Previous $3.06 Million
49.8%
% of portfolio
0.05%
Previous 0.09%
Shares
11 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
60.7MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$102 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$94.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$78.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$75.6 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$71.7 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $942M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...